Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients

Aylin Yilmaz, Victoria Watson, Laura Else, Magnus Gisslèn

Research output: Contribution to journalArticlepeer-review

59 Citations (Scopus)

Abstract

In order to assess the penetration of maraviroc to the central nervous system, we measured maraviroc concentrations in cerebrospinal fluid (CSF) and plasma. Concentrations were determined by liquid chromatography tandem mass spectrometry (lower limit of quantitation 1.25 ng/ml) in seven paired CSF and plasma samples. The median plasma maraviroc concentration was 94.9 ng/ml (range 21.4-478.0) and the median CSF concentration was 3.63 ng/ml (range 1.83-12.2). CSF samples exceeded the median EC90 for maraviroc (0.57 ng/ml) by at least three-fold. The CSF levels of maraviroc found in this study likely contribute to viral suppression in the CSF.
Original languageEnglish
Pages (from-to)2537-2540
Number of pages4
JournalAIDS
Volume23
Issue number18
DOIs
Publication statusPublished - 1 Nov 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients'. Together they form a unique fingerprint.

Cite this